ClinicalTrials.gg
Status unknownNCT06689345Updated Nov 14, 2024

Effect of Non-Invasive Neuromodulation on Primary Chronic Pain, Including Post-COVID-19

An interventional study of taVNS - transauricular vagal nerve stimulation and rPMS - repetitive peripheric magnetic stimulation in Post COVID Condition, Chronic Pain and Healthy, sponsored by Federal University of ABC. Status unknown at 1 site in Brazil. Open to participants aged 18 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-11-14.

Sponsored by Federal University of ABC · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2024), so the status shown — last known as Enrolling by invitation — may be out of date.

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Apr 2024, registered Sep 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
55
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
All
01

Study summary

The aim of this study is to analyse whether there is an advantage in adding low-intensity electrical stimulations to the vagus nerve with electrodes in the outer ear to control pain and fatigue in people with primary chronic pain, and in people who have had COVID-19. Several studies have shown that many people with primary chronic pain and also people who have had COVID patients continue to have pain and fatigue that may be due to changes that occur in the brain and the vagus nerve that passes through the neck might cause inflammation. Therefore the aim of this study is to investigate if these electrical stimulations can help improve the condition of the brain and nerve and consequently, the inflammation so that these complaints improve.

This study will be organized as the following: It will begin with an assessment, divided into a part with questionnaires and another with specific tests. The questionnaires are aimed at understanding volunteer's characteristics, pain, fatigue, inflammation, sleep, quality of life, and the presence of symptoms of anxiety and depression. Next, the volunteer will undergo two tests to assess the behavior of his/her brain. They are performed using EEG electroencephalography and transcranial magnetic stimulation (TMS).

  • Quantitative EEG at rest - In this technique, a cap with electrodes is placed on volunteer's head, in contact with hair, which are connected through a gel. The volunteer needs to remain still for 6 minutes with eyes closed, sitting in a comfortable chair.
  • TMS with EEG - First, the volunteer will be asked to honestly answer the questions in the safety questionnaire for using this technique. Honest answers will eliminate the risks associated with this evaluation. Next, the volunteer's skin will be cleaned with alcohol and a special paste and place three self-adhesive electrodes on the muscle of the volunteer's hand, in a muscle called the interosseous, on the side where he/she writes. These electrodes will only capture the electrical activity of the muscle. Next, a series of magnetic pulses will be administered to the volunteer's skull, in the area that controls the hand muscle. It will contract with each pulse and, with this, so that the functioning of this connection can be understood. At the same time, the EEG device will capture the brain activities that occur during this TMS stimulation. During this exam, the volunteer may feel anything from no stimulation to muscle contractions that move his/her hand. Some people also experience redness under the electrodes, fatigue, or muscle/joint pain.

After the assessments, volunteers will be randomly selected to receive neuromodulation sessions using low-intensity electrical stimulation of the vagus nerve, using electrodes in the outer ear (active group), or sessions that only simulate this neuromodulation (sham, or placebo, group). This will occur for five consecutive days, starting on the day of the assessment. This stimulation is very weak and may not even be felt by the person receiving it. This technique is safe and the most that may occur is redness or itching of the skin. A few people may also experience tingling, a burning sensation or momentary local pain, fatigue, drowsiness, difficulty concentrating and a feeling of nervousness during or after the stimulation.

At the end of the 5 days of electrical stimulation, the same initial assessments will be repeated to see if anything has changed in the volunteer's brain, heart rate, blood pressure, pain, fatigue, inflammation, sleep, quality of life, depression, and anxiety.

02

Conditions studied

  • Post COVID Condition
  • Chronic Pain
  • Healthy

Keywords

  • neuromodulation
  • chronic pain
  • covid-19
  • TMS-EEG
  • vagal nerve
03

In context

Post-Acute COVID-19 Syndrome

536 studies on the registry are indexed under Post-Acute COVID-19 Syndrome; 187 are open to participants now.

This study's planned enrollment of 55 is close to the median of 60 across 369 interventional studies indexed under Post-Acute COVID-19 Syndrome.

Browse Post-Acute COVID-19 Syndrome studies →

Lead sponsor

This is the only study on the registry with Federal University of ABC as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy individuals, both sexes, aged between 18 and 40 years (first arm).
  • Diagnosis of primary chronic pain (for more than 3 months), such as fibromyalgia (chronic widespread pain), primary chronic headache and orofacial pain, chronic primary visceral pain, post-COVID pain, and chronic primary musculoskeletal pain;
  • In the case of post-COVID-19 pain, the symptoms must be present for at least 12 weeks. The complaints of pain, fatigue, and/or changes in mental health should have started after infection by SARS-Cov-2.

Exclusion criteria

Exclusion Criteria:

  • Individuals who present dysautonomia;
  • obese individuals with a high abdominal fat index characterized by a waist/hip ratio of 0.80 for women and 0.95 for men;
  • heart disease;
  • diabetes mellitus;
  • vestibular alterations characterized by the Dix-Hallpike maneuver, supine rotation test, arc test, side-lying maneuver, and post-head-shake nystagmus;
  • diagnosis of epilepsy or first-degree family history of epilepsy
  • fever;
  • chronic consumption of alcohol, or other recreational drugs;
  • presence of contraindications for the use of non-invasive neuromodulation;
  • those who become ill with COVID-19 during the data collection period;
  • those who are unable to answer the evaluation questionnaires;
  • those with clinical instability;
  • those who have a previous history of chronic pain or fatigue before contracting COVID-19;
  • those who have neuropathic pain.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Double (Participant, Investigator)
Enrollment
55 participants (estimated)

Study arms

  • Other
    Healthy subjects

    Once a week, each subject will receive a random stimulation in one of the following areas: (i) the afferent portion of the vagal nerve on the Cymba Conchae of the left ear (taVNS); (ii) rPMS on an efferent portion of the vagal nerve on the neck; (iii) rTMS intermittent theta- burst on the left DLPFC; (iv) simulated taVNS (SHAM) on helix left ear or.

    Device: taVNS - transauricular vagal nerve stimulation · Device: rPMS - repetitive peripheric magnetic stimulation · Device: rTMS - repetitive transcranial magnetic stimulation · Device: taVNS sham

  • Experimental
    Chronic Pain and post Covid Syndrom - Active

    These volunteers will receive 30 minutes of taVNS on the afferent portion of the vagal nerve on the ears.

    Device: taVNS - transauricular vagal nerve stimulation

  • Sham comparator
    Chronic Pain and post Covid Syndrom - Sham

    These volunteers will receive 30 minutes of simulated taVNS on the afferent portion of the vagal nerve on the ears. For this, the equipment will be programmed to be on only for 1 minute.

    Device: taVNS sham

Interventions

  • DevicetaVNS - transauricular vagal nerve stimulation

    30 minutes of electrical stimulation on the afferent portion of the vagal nerve on the cymba conchae of the ear, in the following configuration: 30 seg ramp up, 30 seg on, 30 seg off in intensity on which the volunteer feels a light tingling.

  • DevicerPMS - repetitive peripheric magnetic stimulation

    Magnetic stimulation on the efferent portion of the vagal nerve on the neck, on the following configuration: 20Hz, 25 pulses in the trein, in every inhalation, for 20 inhalations with 50% of machine capacity (500 pulses total).

  • DevicerTMS - repetitive transcranial magnetic stimulation

    rTMS intermitent theta- burst on the left DLPFC, on the following configuration: 50 Hz in treins of 5Hz, with 110% of the resting motor limiar and 600 pulses in 3 minutes.

  • DevicetaVNS sham

    Simulated taVNS (SHAM) on helix left ear, that is the same as taVNS, but during only 1 minute

06

What researchers measure

Primary outcomes

  1. Pain

    It will be assessed through the Brief Pain Inventory (BPI), that assess place and pain intensity and its impact in life and by multidimensional pain assessment instruments to evaluate pain experience and self-efficacy

    Time frame: 5 days

Secondary outcomes

  1. Heart rate variability and blood preasure

    It will be done using a chest polar and a sphygmomanometer.

    Time frame: 5 days

  2. Pressure pain threshold.

    Assessed through handgrip dynamometry.

    Time frame: 5 days

  3. TMS-Evoked potential

    TMS-Evoked Potential is a measure derived from TMS stimulus on the brain which represent a brain reactivity to exogenous stimulus

    Time frame: 5 days

  4. Disautonomy, fatigue and mental health

    Dysautonomia will be assessed through TMS-EEG. Fatigue will be assessed by physical, cognitive and psychosocial fatigue scales and fatigue perception questionnaire. Mental health will be assessed by anxiety, depression and sleep quality questionnaires. Quality of life will be assessed by a specific questionnaire.

    Time frame: 5 days

07

Study locations

1 site
  • Federal University of ABC
    Sâo Bernardo Do Campo, São Paulo 09606045, Brazil
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 14, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06689345
Lead sponsor
Federal University of ABC
Collaborators
University of Sao Paulo, Coordination for the Improvement of Higher Education Personnel
Responsible party
Sponsor
First posted
Nov 14, 2024
Start date
Apr 21, 2024
Primary completion
Dec 16, 2024 (estimated)
Completion
Dec 16, 2024 (estimated)
Last update
Nov 14, 2024

Study contacts

Tiago S Lopes, PhD
study chair · Federal University of ABC

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion